Go to the list of all blogs
Allana's Avatar
published in Blogs
Jul 23, 2026
Canadian Natural Resources (CNQ) Surges +14.7% Amid Oil Supply Concerns

Canadian Natural Resources (CNQ) Surges +14.7% Amid Oil Supply Concerns

Key Takeaways

  • Canadian Natural Resources (CNQ) surged approximately 14.7% over the past 30 days, climbing from $41.02 on June 23 to $47.03 as of July 23, 2026, supported by a six-session winning streak.
  • The rally was fueled by a rebound in crude oil prices tied to escalating U.S.-Iran tensions and the closure of the Strait of Hormuz, which disrupted nearly 20% of global oil supply flows.
  • Zacks Research upgraded CNQ from "Hold" to "Strong-Buy" on July 23, while Raymond James had previously raised the stock to "Outperform" in early May, reinforcing bullish analyst sentiment.
  • Over the broader quarter, CNQ experienced significant volatility — reaching highs near $49.42 in mid-May before sliding to a trough of $38.92 in early July, then recovering sharply in recent weeks.
  • The company's strong fundamentals, including a 26-year track record of consecutive dividend increases, a 5.7% dividend yield, and better-than-expected Q1 earnings, continue to anchor investor confidence.
  • Institutional ownership remains robust at 74.03%, with select large investors such as Vanguard Group and WCM Investment Management increasing their positions.

A Closer Look at Canadian Natural Resources (CNQ)

Canadian Natural Resources Limited is a Calgary-based independent oil and natural gas exploration and production company with operations concentrated in Western Canada. The company engages in the full lifecycle of crude oil, natural gas, and natural gas liquids (NGLs) — spanning exploration, development, production, marketing, and sales. Its diversified asset portfolio includes oil sands mining and in-situ thermal projects, conventional light and heavy crude oil, offshore production, and midstream processing and upgrading infrastructure. With a market capitalization of approximately $95 billion and a proven 26-year history of consecutive annual dividend increases, CNQ is one of Canada's largest and most established energy producers. Investors follow the stock closely for its exposure to global commodity cycles, its disciplined capital allocation strategy, and its substantial free cash flow generation capabilities.

CNQ Stock Performance: The Last 30 Days Versus the Quarter

Over the last 30 days, CNQ shares have rallied approximately 14.7%, rising from a close of $41.02 on June 23, 2026, to an intraday price of $47.03 on July 23, 2026. This advance was marked by a six-day consecutive winning streak that added roughly $6.6 billion in market value. The move stands in contrast to the broader S&P 500, which declined approximately 0.6% over the same six-session window, indicating that the buying momentum was company-specific rather than a function of broad market tailwinds.

The quarterly picture reveals a more turbulent journey. From late April, when CNQ traded near $45.43, the stock climbed to a quarterly peak of $49.42 on May 19 before succumbing to a sharp downturn that accelerated through June. By July 1, shares had fallen to $38.92 — a decline of roughly 21% from the May high — pressured by weakening crude prices and macroeconomic uncertainty. The subsequent recovery lifted the stock back toward $47, translating to a modest net quarterly gain of about 3.5%, but the intra-quarter volatility underscores the stock's sensitivity to commodity price swings and geopolitical developments.

Drivers Behind the Recent 30-Day Rally in CNQ

The primary catalyst behind CNQ's recent surge has been the sharp rebound in crude oil prices, triggered by escalating military conflict between the United States and Iran. The ongoing closure of the Strait of Hormuz — a critical chokepoint through which roughly 20% of global oil supply normally transits — has tightened supply expectations and pushed benchmark crude prices higher. As a major Canadian producer with significant heavy crude and oil sands output, CNQ directly benefits from rising oil prices.

On the analyst front, Zacks Research upgraded CNQ from "Hold" to "Strong-Buy" on July 23, reflecting growing conviction in the stock's near-term upside. Earlier in the quarter, Raymond James upgraded the stock from "Market Perform" to "Outperform" on May 7, citing improving fundamentals. The consensus analyst rating now stands at "Moderate Buy" with an average price target of $57.00, implying substantial upside from current levels. Additionally, Desjardins raised its rating to "Hold" on July 16, and Scotiabank followed with a similar upgrade on June 26, signaling a broadly improving sentiment on Wall Street.

Institutional flows have also provided a tailwind. Multiple institutional investors — including Barometer Capital Management, WCM Investment Management (which boosted its stake by 22.4%), and Bleakley Financial Group (up 59.8%) — added to their positions during the most recent reporting periods. Overall institutional ownership remains elevated at 74.03%.

Quarterly Performance Drivers for CNQ

The quarterly performance of CNQ was shaped by two opposing forces: strong company-specific fundamentals and volatile macroeconomic conditions. On the positive side, the company reported first-quarter earnings on May 7 that exceeded expectations, posting $0.85 per share versus the $0.74 consensus estimate, with revenue of $7.72 billion also topping forecasts of $7.57 billion. The earnings beat, combined with the Raymond James upgrade on the same day, propelled the stock toward the $49.42 quarterly high by mid-May.

However, the broader energy sector faced headwinds in late May and June as global demand concerns, a temporarily stronger U.S. dollar, and uncertainty around OPEC+ production policy weighed on crude prices. CNQ's stock fell roughly 21% from its May peak to the July 1 trough, mirroring the sector-wide selloff. The subsequent recovery has been driven by the geopolitical supply disruption in the Strait of Hormuz and recognition among investors that CNQ's diversified asset base, low-cost production structure, and disciplined balance sheet position it well to navigate cycles. The company's consistent dividend policy — including the $0.625 per share quarterly dividend paid on July 7 — provided a steady income signal that likely attracted value-oriented buyers during the selloff.

Systematic Approaches Worth Considering for CNQ

When evaluating systematic trading approaches for stocks like CNQ, I frequently review Tickeron’s Trending AI Robots page. It offers a curated view of top-performing AI-powered trading bots covering thousands of tickers across multiple asset classes, with only the most relevant and consistently high-performing strategies highlighted. Each bot varies by trading style, holding period, and risk parameters — ranging from short-term swing trading to longer-duration trend-following approaches — allowing users to evaluate performance metrics, track records, and strategy logic before making decisions. Exploring the Trending AI Robots page can help traders identify systematic approaches aligned with current market conditions.

Key Factors to Watch for CNQ Going Forward

Looking ahead, the single largest factor influencing CNQ's trajectory remains the path of crude oil prices, which will be heavily dictated by developments in the U.S.-Iran conflict and the status of the Strait of Hormuz. Any diplomatic resolution that restores normal shipping flows could unwind recent supply-premium gains.

On the corporate front, CNQ's next quarterly earnings report will be closely scrutinized for updated production guidance, capital expenditure plans, and free cash flow generation — all critical metrics that underpin the company's ability to sustain and grow its dividend. Analysts currently project full-year EPS of approximately $4.20, a figure that will be tested against evolving commodity prices.

Broader macroeconomic considerations — including U.S. Federal Reserve interest rate policy, Canadian dollar exchange rate fluctuations, and global industrial demand — will also shape investor sentiment around energy equities. Additionally, investors should monitor Canada's evolving energy export infrastructure landscape, including potential new pipeline and LNG terminal projects that could expand market access for Canadian producers like CNQ. Regulatory developments around emissions policy and oil sands production caps in Canada represent longer-term structural considerations for the stock.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CNQ

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


CNQ in upward trend: 10-day moving average crossed above 50-day moving average on July 24, 2026

The 10-day moving average for CNQ crossed bullishly above the 50-day moving average on July 24, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 20 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 10, 2026. You may want to consider a long position or call options on CNQ as a result. In of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CNQ just turned positive on August 10, 2026. Looking at past instances where CNQ's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

CNQ moved above its 50-day moving average on July 21, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CNQ advanced for three days, in of 375 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 292 cases where CNQ Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for CNQ moved out of overbought territory on July 27, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator moved out of overbought territory. In of the 32 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CNQ declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CNQ broke above its upper Bollinger Band on July 23, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CNQ’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.921) is normal, around the industry mean (7.499). P/E Ratio (11.795) is within average values for comparable stocks, (22.633). Projected Growth (PEG Ratio) (3.419) is also within normal values, averaging (2.483). Dividend Yield (0.036) settles around the average of (0.086) among similar stocks. P/S Ratio (2.698) is also within normal values, averaging (5.536).

Notable companies

The most notable companies in this group are ConocoPhillips (NYSE:COP), Canadian Natural Resources Limited (NYSE:CNQ), EOG Resources (NYSE:EOG), Occidental Petroleum Corp (NYSE:OXY), Diamondback Energy (NASDAQ:FANG), Devon Energy Corp (NYSE:DVN), EQT Corp (NYSE:EQT), Expand Energy Corporation (NASDAQ:EXE), APA Corp (NASDAQ:APA), ANTERO RESOURCES Corp (NYSE:AR).

Industry description

The oil and gas production segment includes companies that specialize in exploration, development, and production of oil and natural gas. These companies are focused on upstream operations. Companies typically identify deposits, drill wells, and extract raw materials from underground. The industry also includes related services like rig operations, feasibility studies, machinery rentals etc. Several operators in this industry work with various types of contractors such as engineering procurement and construction contractors, as well as with joint-venture partners and oil field service companies. Oil and gas often involves large fixed costs of production; so, declining crude oil prices, for example, is a potential negative for this industry. Conoco Phillips, EOG Resources, Inc. and Pioneer Natural Resources Company are some examples of companies operating in this space.

Market Cap

The average market capitalization across the Oil & Gas Production Industry is 10.05B. The market cap for tickers in the group ranges from 3.28K to 152.93B. COP holds the highest valuation in this group at 152.93B. The lowest valued company is PSTRQ at 3.28K.

High and low price notable news

The average weekly price growth across all stocks in the Oil & Gas Production Industry was 6%. For the same Industry, the average monthly price growth was 4%, and the average quarterly price growth was 6%. NOG experienced the highest price growth at 22%, while GLND experienced the biggest fall at -50%.

Volume

The average weekly volume growth across all stocks in the Oil & Gas Production Industry was -20%. For the same stocks of the Industry, the average monthly volume growth was -8% and the average quarterly volume growth was -41%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 49
P/E Growth Rating: 52
Price Growth Rating: 50
SMR Rating: 74
Profit Risk Rating: 72
Seasonality Score: 2 (-100 ... +100)
View a ticker or compare two or three
CNQ
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a company which engages in exploration and development of crude oil and gas properties

Industry OilGasProduction

Profile
Details
Industry
Oil And Gas Production
Address
855 - 2nd Street South West
Phone
+1 403 517-6700
Employees
10272
Web
https://www.cnrl.com
Interact to see
Advertisement
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Canadian Natural Resources (CNQ) Surges +14.7% Amid Oil Supply Concerns